LY-4006895 / Eli Lilly - LARVOL DELTA

J5K-MC-OQAA: A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) (clinicaltrials.gov) - P1 | N=68 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting

Enrollment open • Alzheimer's Disease • CNS Disorders